Showing results (751-760 of 1,154) with videos related to
Sort By:
Pageof 116
Cancers|November 27, 2021
Cyclin E1 in Murine and Human Liver Cancer: A Promising Target for Therapeutic Intervention during Tumour ProgressionRoland Sonntag, Christian Penners, Marlene Kohlhepp, et al.Hepatology (Baltimore, Md.)|October 5, 2010
Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosisChristoph Roderburg, Gerd-Willem Urban, Kira Bettermann, et al.BMC Gastroenterology|April 5, 2013
Serum sodium based modification of the MELD does not improve prediction of outcome in acute liver failurePaul Manka, Lars P Bechmann, Frank Tacke, et al.Hepatology Communications|March 27, 2023
Hepatic C-X-C chemokine receptor type 6-expressing innate lymphocytes limit detrimental myeloid hyperactivation in acute liver injuryFelix Heymann, Jana C Mossanen, Moritz Peiseler, et al.International Journal of Molecular Sciences|August 27, 2021
The Role of miRNA in the Pathophysiology of Neuroendocrine TumorsLukas Geisler, Raphael Mohr, Joeri Lambrecht, et al.Journal of Visualized Experiments : Jove|April 14, 2015
Long term intravital multiphoton microscopy imaging of immune cells in healthy and diseased liver using CXCR6.Gfp reporter miceFelix Heymann, Patricia M Niemietz, Julia Peusquens, et al.Disease Markers|November 28, 2019
Serum Levels of Kisspeptin Are Elevated in Patients with Pancreatic CancerSven H Loosen, Mark Luedde, Georg Lurje, et al.Medicina (Kaunas, Lithuania)|December 23, 2022
A Reduction of Calcineurin Inhibitors May Improve Survival in Patients with De Novo Colorectal Cancer after Liver TransplantationRamin Raul Ossami Saidy, Elisa Wegener, Deniz Uluk, et al.Plos One|December 31, 2020
Serum levels of miR-223 but not miR-21 are decreased in patients with neuroendocrine tumorsTeresa Hellberg, Raphael Mohr, Lukas Geisler, et al.Journal of Hepatology|May 26, 2026
EASL position paper on preclinical models of steatotic liver diseaseSuchira Gallage, Rui E Castro, Jennifer Estall, et al.Pageof 116